|
|
||||||||
Articles |
1
Department of Clinical Chemistry, Ghent University Hospital, De Pintelaan 185, B9000 Ghent, Belgium.
2
Departments of Medicine and Chemical Pathology, Medical
School, The University of Zimbabwe, Avondale, Harare, Zimbabwe.
3
Department of Clinical Chemistry, Middelheim Hospital,
Lindendreef 1, B2020 Antwerp, Belgium.
4
Department of Clinical Chemistry, AZ Stuivenberg, Lange
Beeldekensstraat 267, B2060 Antwerp, Belgium.
5
Analis SA, 14 Rue Dewez, B5000 Namur, Belgium.
a Address correspondence to this author at: Department of Clinical Chemistry, De Pintelaan 185, B-9000 Gent, Belgium. Fax 32-9-240-4985; e-mail joris.delanghe{at}rug.ac.be.
Background: Current methods for carbohydrate-deficient transferrin (CDT) often suffer from low precision, complexity, or risk of false positives attributable to genetic variants. In this study, a new capillary zone electrophoresis (CZE) method for CDT was developed.
Methods: CZE was performed on a P/ACE 5000 using fused-silica capillaries [50 µm (i.d.) x 47 cm] and the CEOFIX CDT buffer system with addition of 50 µL of anti-C3c and 10 µL of anti-hemoglobin. Native sera were loaded by high-pressure injection for 3 s, separated at 28 kV over 12 min, and monitored at 214 nm.
Results: CDT was completely resolved by differences in migration times (di-trisialotransferrin, 9.86 ± 0.05 min; monosialotransferrin, 9.72 ± 0.05 min; asialotransferrin, 9.52 ± 0.04 min), with a CV of 0.15%. The number of theoretical plates was 312 000 ± 21 000 for the mono- and 199 000 ± 6500 for the di-trisialylated transferrin. Genetic CB and CD variants showed prominent peaks with migration times of 10.12 ± 0.06 and 9.89 ± 0.03 min, respectively, and the carbohydrate-deficient glycoprotein syndrome could be detected, excluding false-positive results. CZE results (as a percentage; y) correlated with the Axis %CDT TIATM (x) values by Deming regression analysis: y = 1.92x - 7.29; r = 0.89. CDT values in 130 healthy nonalcoholics were determined. The 2.5th and 97.5th percentiles were 1.84% and 6.79%.
Conclusions: CZE without sample pretreatment can determine CDT with good precision, allows detection of variants, and correlates with ion-exchange chromatography.
The following articles in journals at HighWire Press have cited this article:
![]() |
J. R. Delanghe, A. Helander, J. P.M. Wielders, J. M. Pekelharing, H. J. Roth, F. Schellenberg, C. Born, E. Yagmur, W. Gentzer, and H. Althaus Development and Multicenter Evaluation of the N Latex CDT Direct Immunonephelometric Assay for Serum Carbohydrate-Deficient Transferrin Clin. Chem., June 1, 2007; 53(6): 1115 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Carchon, R. Chevigne, J.-B. Falmagne, and J. Jaeken Diagnosis of Congenital Disorders of Glycosylation by Capillary Zone Electrophoresis of Serum Transferrin Clin. Chem., January 1, 2004; 50(1): 101 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Legros, V. Nuyens, M. Baudoux, K. Zouaoui Boudjeltia, J.-L. Ruelle, J. Colicis, F. Cantraine, and J.-P. Henry Use of Capillary Zone Electrophoresis for Differentiating Excessive from Moderate Alcohol Consumption Clin. Chem., March 1, 2003; 49(3): 440 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Whitfield Transferrin Isoform Analysis for the Diagnosis and Management of Hazardous or Dependent Drinking Clin. Chem., December 1, 2002; 48(12): 2095 - 2096. [Full Text] [PDF] |
||||
![]() |
F. J. Legros, V. Nuyens, E. Minet, P. Emonts, K. Z. Boudjeltia, A. Courbe, J.-L. Ruelle, J. Colicis, F. de L'Escaille, and J.-P. Henry Carbohydrate-deficient Transferrin Isoforms Measured by Capillary Zone Electrophoresis for Detection of Alcohol Abuse Clin. Chem., December 1, 2002; 48(12): 2177 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tagliaro, F. Bortolotti, R. M. Dorizzi, M. Marigo, J. R. Delanghe, B. Wuyts, and M. L. De Buyzere Caveats in Carbohydrate-deficient Transferrin Determination Drs. Delanghe, Wuyts, and De Buyzere respond: Clin. Chem., January 1, 2002; 48(1): 208 - 209. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |